Healthcare technology company Wolters Kluwer Health (EURONEXT: WKL) announced on Monday that it has achieved significant milestones with AI Labs, the Clinical Generative AI (GenAI) beta, powered by UpToDate, a trusted clinical decision support solution.

AI Labs, the only Large Language Model exclusively trained on UpToDate content, now has access to the complete set of evidence-based clinical content and recommendations across 25 medical specialties.

With the launch of UpToDate Enterprise Edition, over 100 US hospitals and major health systems gain access to AI Labs' testing and validation program, a crucial step in establishing Clinical GenAI as a reliable point-of-care solution. Addressing concerns about GenAI in healthcare, AI Labs ensures transparency and validation of medical information, aligning with responsible clinical practices.

Wolters Kluwer's approach to GenAI in clinical settings earns recognition as a healthcare technology pioneer by Frost & Sullivan. Demonstrations of AI Labs will be featured at the HIMSS24 Global Conference and Exhibition at Wolters Kluwer's booth, #2927.

Wolters Kluwer, a global leader in information and software solutions for various professional sectors, reported annual revenues of EUR5.6bn in 2023. With a focus on healthcare, tax, accounting and other domains, the company is dedicated to supporting critical decision-making through expert solutions and innovative technology.